Average Co-Inventor Count = 4.91
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biohaven Therapeutics Ltd. (11 from 28 patents)
2. The Wistar Institute of Anatomy & Biology (7 from 157 patents)
3. Biohaven Pharmaceutical Holding Company Limited (7 from 8 patents)
4. Rutgers, the State University of New Jersey (4 from 1,451 patents)
5. Promentis Pharmaceuticals, Inc. (4 from 9 patents)
6. The Wistar Institute (2 from 84 patents)
7. Merck Patent Gmbh (1 from 2,931 patents)
8. Fox Chase Chemical Diversity Center, Inc. (1 from 1 patent)
9. Advanced Neural Dynamics, Inc. (1 from 1 patent)
33 patents:
1. 12472165 - Riluzole prodrugs and their use
2. 12343347 - Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis
3. 12295942 - Riluzole prodrugs and their use
4. 12258314 - EBNA1 inhibitors and their method of use
5. 12213965 - Riluzole prodrugs and their use
6. 12172974 - Prodrugs of riluzole and their method of use
7. 12116359 - EBNA1 inhibitor crystalline forms, and methods of preparing and using same
8. 12005047 - Riluzole prodrugs and their use
9. 12005046 - Riluzole prodrugs and their use
10. 11912659 - EBNA1 inhibitors and methods using same
11. 11911369 - Prodrugs of riluzole and their method of use
12. 11440893 - Prodrugs of riluzole and their method of use
13. 11242338 - EBNA1 inhibitor crystalline forms, and methods of preparing and using same
14. 11242317 - EBNA1 inhibitors and their method of use
15. 11197864 - Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis